Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Nihon Kohden Corporation ( (JP:6849) ) has provided an update.
Nihon Kohden Corporation announced its decision to acquire additional shares of its subsidiary, NeuroAdvanced Corp. (NAC), making it a wholly owned subsidiary. This acquisition follows a put option exercised by NeuroNewCo, LP, allowing Nihon Kohden to purchase the remaining 28.6% shares of NAC. The acquisition, scheduled for completion on July 9, 2025, will have a minor impact on the company’s consolidated results for FY2025, as NAC and its subsidiary Ad-Tech are already consolidated entities.
The most recent analyst rating on (JP:6849) stock is a Sell with a Yen1500.00 price target. To see the full list of analyst forecasts on Nihon Kohden Corporation stock, see the JP:6849 Stock Forecast page.
More about Nihon Kohden Corporation
Nihon Kohden Corporation operates in the medical equipment industry, focusing on the development and manufacturing of innovative medical devices and technologies. The company is known for its products in patient monitoring, medical electronics, and healthcare information technology, catering to a global market.
Average Trading Volume: 689,314
Technical Sentiment Signal: Sell
Current Market Cap: Yen284.9B
See more data about 6849 stock on TipRanks’ Stock Analysis page.